Skip to content

The Tether™ - Vertebral Body Tethering System Post Approval Study

The Tether™ - Vertebral Body Tethering System Post Approval Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04505579
Enrollment
200
Registered
2020-08-10
Start date
2020-10-29
Completion date
2027-12-31
Last updated
2024-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scoliosis Idiopathic

Brief summary

This study is an opportunity to provide continued reasonable assurance of the safety and probable benefit of The Tether HUD. The study will collect long term safety and efficacy information from patients who have had their idiopathic scoliosis treated via anterior vertebral body tethering (AVBT) with The Tether.

Detailed description

While spinal fusion remains the standard surgical treatment for progressive idiopathic scoliosis, concerns about the long-term effects of spinal fusion have led to the investigation of growth-modulation techniques. Anterior Vertebral Body Tethering (AVBT) is one such technique that utilizes growth modulation to remodel the shape of the vertebra and straighten scoliotic curves in skeletally immature individuals. In this technique, screws are inserted at each vertebral level for the length of the convex side of the curve. A strong cord is connected through the screw tulip heads and used to initially straighten the curve as each level is fixed with a set screw. Following surgery and during the growth period the spine begins to remodel according to the Hueter-Volkmann Law, bone growth is relatively inhibited in areas of increased pressure (convex or tethered side) and relatively stimulated in areas of decreased pressure or tension (concave side). Following this principle, AVBT has been shown to alter spinal growth with the potential to correct scoliosis while maintaining spine flexibility. The objective of the study is to assess the ongoing safety and probable benefit of The Tether HUD which was approved by the FDA under an HDE. Subject enrollment and data collection will be managed by the Harms Study Group (HSG) and Setting Scoliosis Straight Foundation (SSSF) Registry. Institutions that are HSG members or affiliates, with Investigators/surgeons that are trained and approved to perform surgeries with The Tether, will participate in the registry. Ten sites from this group will be identified as study sites specific to this Tether post-approval study (PAS). Consecutive subjects from these sites, that meet the eligibility criteria of this study, will be flagged in the registry as the PAS cohort and the study endpoints will be assessed across this population.

Interventions

Anterior Vertebral Body Tethering (AVBT) is a technique that utilizes growth modulation to remodel the shape of the vertebra and straighten scoliotic curves in skeletally immature individuals. In this technique, screws are inserted at each vertebral level for the length of the convex side of the curve. A strong cord is connected through the screw tulip heads and used to initially straighten the curve as each level is fixed with a set screw. Following surgery and during the growth period the spine begins to remodel according to the Hueter-Volkmann Law, bone growth is relatively inhibited in areas of increased pressure (convex or tethered side) and relatively stimulated in areas of decreased pressure or tension (concave side).

Sponsors

Setting Scoliosis Straight Foundation
CollaboratorOTHER
Exponent, Inc.
CollaboratorUNKNOWN
ZimVie
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Diagnosis of progressive idiopathic scoliosis * Skeletally immature, based on both Risser (\<5) and Sanders (\<8) assessments * Major Cobb angle ≥30° and ≤65° * Osseous structure dimensionally adequate to accommodate screw fixation, as determined by radiographic imaging * Failed or intolerant to bracing

Exclusion criteria

* Presence of any systemic infection, local infection, or skin compromise at the surgical site * Prior spinal surgery at the level(s) to be treated * Documented poor bone quality, defined as a T-score -1.5 or less * Any other medical or surgical condition which would preclude the potential benefit of spinal surgery, such as coagulation disorders, allergies to the implant materials, and patient's unwillingness or inability to cooperate with post-operative care instructions * Unwillingness, inability, or living situation (e.g. custody arrangements, homelessness, detention) that would preclude ability to return to the study site for follow-up visits as described in protocol and Informed Consent * Unwillingness to sign Informed Consent Form and participate in study procedures

Design outcomes

Primary

MeasureTime frameDescription
Rate of SAEs and device- &/or procedure-related AEsAVBT surgery to five year post-opThe primary safety endpoint is the rate of Serious Adverse Events (SAEs) and device- and/or procedure-related Adverse Events (AEs)
Percentage of subjects with maintenance of the major Cobb angle less than or equal to 40 degrees at 60 months post-surgeryAVBT surgery to five year post-opThe primary probable benefit endpoint is the percentage of patients with maintenance of the major Cobb angle less than or equal to 40 degrees at 60 months post-surgery

Secondary

MeasureTime frameDescription
ReoperationAVBT surgery to five year post-opRates and types of reoperation
Number of participants with secondary curves that progress to the point of clinical significance.AVBT surgery to five year post-opDetermined by radiographic assessment, typically defined as an increase in secondary Cobb angle measurement greater than or equal to 10 degrees, or medical intervention/ intent to treat.
Number of participants with device integrity failures including cord breakage and screw migration.AVBT surgery to five year post-op
Mean (SD) and distributions of sagittal balance (mm) from pre-op through last visitBaseline to five year post-opSagittal balance is assessed on the lateral radiograph by measuring the difference (i.e. distance) between posterosuperior aspect of the S1 vertebral body and the plumb line.
Number of participants with new curves that develop above or below the tethered portion of the spine.AVBT surgery to five year post-opDetermined by radiographic assessment, defined as a new curve development with Cobb angle measurement greater than or equal to 40 degrees.
Mean score of Scoliosis Research Society 22r Patient QuestionnaireBaseline to five year post-opSelf-reported outcomes of function, pain, self-image, mental health, and satisfaction. Mean score; 5 (Best) - 1 (Worst)
Number of participants with compromised lung functionBaseline to five year post-opComparison of the measured lung function (forced expiratory volume (FEV1), forced vital capacity (FVC) and FEV1/FVC) to predicted values, lower and upper limits of normal to determine if lung function is within the limits of the normal population.
Measurement (degrees rotation) of trunk shape by scoliometer device. Mean (SD) [min, max] will be reported.Baseline to five year post-opMeasurements of trunk shape or rib hump will be collected preoperatively and at each follow-up visit. A standard scoliometer device will be used to measure the rib hump in the thoracic and/or lumbar regions of the spine, as applicable. The scoliometer is laid across the curve at right angles with the 0° mark at the spinous process and resting gently on the skin, not pressed down. The degrees of rotation are read and recorded.
Trunk flexibility as determined by distance (cm) of flexion and lateral bend using fingertip to floor method.Baseline to five year post-op
Mean (SD) and distributions of lumbar lordosis (degrees) from pre-op through last visit.Baseline to five year post-opLumbar lordosis is defined as the angle at the intersection of lines perpendicular to lines parallel to the superior endplate of T12 and the superior endplate of S1.
Adverse EventsAVBT surgery to five year post-opRates of overall Adverse Events; relatedness, severity, time to event

Countries

United States

Contacts

Primary ContactMonica Barascout, BS
Monica.Barascout@zimvie.com1-303-465-8960
Backup ContactKim Martinez
Kim.Martinez@zimvie.com1-303-465-8960

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026